亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

三七素 CAS:5302-45-4

 
 
單價 面議對比
詢價 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:22
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會員第5年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

nkl-00147
中文名稱:三七素
中文別名:3-N-草酰-L-2,3-二氨基丙酸
英文名稱:dencichine
英文別稱:Dencichin; Dencichine; L-3-Oxalylamino-2-aminopropionic acid;β-N-Oxalyl-L-α,β-diaminopropionate; L-Dencichin; Neurotoxin (Lathyrus ativus); Nβ-Oxalylamino-L-alanine;
CAS號:5302-45-4
純度: HPLC≥98%

分子式:C5 H8 N2 O5
分子量:176.13
外觀:白色粉末
密度:1.596±0.06克/立方厘米|條件:溫度:20°C
pKa:1.99±0.10 |條件:酸性最強(qiáng)溫度:25°C
提取來源:三七
藥理藥效:抗心律失常、抗心機(jī)損傷、降血壓
檢測條件:甲醇∶水(70:30),檢測波長:214nm(僅供參考)
規(guī)格:10mg,20mg,50mg;可根據(jù)客戶需求包裝、定制

儲存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實(shí)驗(yàn)、活性篩選等科研、實(shí)驗(yàn)室使用;不得直接用于人體

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
2”-O-沒食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |